Reply to Rongkang Li, Lei Peng, Shaohua Zhang, and Song Wu's Letter to the Editor re: Johan Bjerner, Ola Bratt, Kirsti Aas, et al. Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium. Eur Urol 2024;86:20-6.

Autor: Bjerner J; Department of Clinical Chemistry, Fürst Laboratories, Oslo, Norway., Bratt O; Department of Urology, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden., Aas K; Department of Urology, Oslo University Hospital, Oslo, Norway., Albertsen PC; Division of Urology, Department of Surgery, University of Connecticut Health Center, Farmington, CT, USA., Carlsson SV; Department of Urology, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Oldenburg J; Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Akershus University Hospital, Lørenskog, Norway. Electronic address: jan.oldenburg@medisin.uio.no.
Jazyk: angličtina
Zdroj: European urology [Eur Urol] 2024 Sep 17. Date of Electronic Publication: 2024 Sep 17.
DOI: 10.1016/j.eururo.2024.08.034
Databáze: MEDLINE